Stockscreener 앱 받기
32.30
1.19%
0.38
시장 영업 전:
32.55
0.25
+0.77%
전일 마감가:
$31.92
열려 있는:
$31.97
하루 거래량:
506.97K
Relative Volume:
0.65
시가총액:
$3.61B
수익:
$418.33M
순이익/손실:
$-252.07M
주가수익비율:
-13.46
EPS:
-2.4
순현금흐름:
$-238.84M
1주 성능:
+2.57%
1개월 성능:
-9.60%
6개월 성능:
-15.45%
1년 성능:
+56.19%
1일 변동 폭
$31.68
$32.48
1주일 범위
$26.66
$33.06
52주 변동 폭
$20.17
$44.34
Zai Lab Limited Adr Stock (ZLAB) Company Profile
명칭
Zai Lab Limited Adr
전화
862161632588
주소
4560 JINKE ROAD, SHANGHAI
ZLAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZLAB
Zai Lab Limited Adr
|
32.30 | 3.55B | 418.33M | -252.07M | -238.84M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.36 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.06 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
752.32 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-25 | 재개 | Jefferies | Buy |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2025-03-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-12-14 | 개시 | Morgan Stanley | Overweight |
| 2023-08-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-01-21 | 개시 | Macquarie | Outperform |
| 2021-10-12 | 개시 | Bernstein | Mkt Perform |
| 2020-04-28 | 개시 | Goldman | Buy |
| 2020-04-15 | 개시 | Guggenheim | Buy |
| 2019-07-12 | 개시 | BofA/Merrill | Buy |
| 2019-07-05 | 개시 | Macquarie | Outperform |
| 2019-01-29 | 개시 | Credit Suisse | Outperform |
| 2018-11-21 | 개시 | Jefferies | Buy |
| 2018-06-21 | 재개 | Leerink Partners | Outperform |
| 2018-02-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2017-10-16 | 개시 | JP Morgan | Neutral |
| 2017-10-16 | 개시 | Leerink Partners | Outperform |
모두보기
Zai Lab Limited Adr 주식(ZLAB)의 최신 뉴스
Insider Buying: Zai Lab (NASDAQ:ZLAB) Insider Purchases 10,000 Shares of Stock - MarketBeat
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives $56.35 Average PT from Brokerages - Defense World
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Woodline Partners LP Sells 558,781 Shares of Zai Lab Limited Unsponsored ADR $ZLAB - MarketBeat
Zai Lab Limited ADR (NASDAQ: ZLAB) Is Up 14.37% – Is It Capable Of A Rally? - stocksregister.com
Zai Lab (NASDAQ:ZLAB) Shares Gap UpHere's What Happened - MarketBeat
Zai Lab (NASDAQ:ZLAB) Shares Gap DownHere's Why - MarketBeat
FY2026 EPS Estimates for Zai Lab Reduced by Leerink Partnrs - MarketBeat
Market Sentiment Around Loss-Making Zai Lab Limited (NASDAQ:ZLAB) - 富途牛牛
Raymond James Financial Inc. Boosts Holdings in Zai Lab Limited Unsponsored ADR $ZLAB - MarketBeat
Cubist Systematic Strategies LLC Increases Stake in Zai Lab Limited Unsponsored ADR $ZLAB - MarketBeat
Zai Lab's Double Whammy: Earnings Miss, Phase 3 Setback - Benzinga
Zai Lab FY2026 EPS Forecast Lowered by Leerink Partnrs - Defense World
Zai Lab (NASDAQ:ZLAB) Shares Down 5.8%Here's What Happened - MarketBeat
MPM Bioimpact LLC Acquires 33,659 Shares of Zai Lab Limited Unsponsored ADR $ZLAB - MarketBeat
Frazier Life Sciences Management L.P. Makes New Investment in Zai Lab Limited Unsponsored ADR $ZLAB - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zai Lab LimitedZLAB - FinancialContent
C3.ai Posts Downbeat Results, Joins GitLab, Salesforce… - inkl
C3.ai Posts Downbeat Results, Joins GitLab, Salesforce And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Zai Lab: to await results of Fortitude-102 prior to reg. filing - AInvest
Zai Lab Limited Unsponsored ADR $ZLAB Shares Sold by Russell Investments Group Ltd. - MarketBeat
First ADC Therapy for Cervical Cancer: Zai Lab's TIVDAK Gets Hong Kong Regulatory Green Light - Stock Titan
Zai Lab Announces Approval of TIVDAK® for Patients with Recurrent or Metastatic Cervical Cancer in Hong Kong - Business Wire
Zai Lab Limited Unsponsored ADR $ZLAB Shares Purchased by Invesco Ltd. - Defense World
How high can Zai Lab Limited Depositary Receipt stock goTrade Signal Summary & Risk Adjusted Buy and Sell Alerts - Newser
Zai Lab Announces Participation in Investor Conferences in June 2025 - FinancialContent
Zai Lab Limited Depositary Receipt stock chart pattern explained2025 Geopolitical Influence & Weekly Breakout Watchlists - Newser
Can trapped investors hope for a rebound in Zai Lab Limited Depositary Receipt2025 Year in Review & Low Risk High Reward Trade Ideas - Newser
Should you hold or exit Zai Lab Limited Depositary Receipt now2025 Technical Overview & Free Fast Entry Momentum Trade Alerts - Newser
Predicting Zai Lab Limited Depositary Receipt trend using moving averagesProduct Launch & Reliable Price Action Trade Plans - Newser
Price momentum metrics for Zai Lab Limited Depositary Receipt explainedJuly 2025 Gainers & Capital Protection Trading Alerts - Newser
Nuveen LLC Makes New $3.27 Million Investment in First Advantage Co. $FA - Defense World
Zai Lab Announces Participation in Investor Conferences in September 2025 - The Globe and Mail
Russell Investments Group Ltd. Sells 193,978 Shares of Zai Lab Limited Unsponsored ADR $ZLAB - Defense World
Zai Lab to Participate in Investor Conferences in September 2025 - AInvest
Amazon.com, Inc. $AMZN Shares Purchased by Woodard & Co. Asset Management Group Inc. ADV - Defense World
Twelve Points Wealth Management LLC Has $3.93 Million Stock Position in Apple Inc. $AAPL - Defense World
Beacon Bridge Wealth Partners LLC Increases Holdings in Amazon.com, Inc. $AMZN - Defense World
Vanguard Group Inc. Has $33.65 Million Stock Holdings in MGP Ingredients, Inc. $MGPI - Defense World
Charles Schwab Investment Management Inc. Has $6.05 Million Stock Position in SPDR S&P 600 Small Cap Value ETF $SLYV - Defense World
Cornerstone Planning Group LLC Has $6.06 Million Stock Position in Apple Inc. $AAPL - Defense World
Here's What Key Metrics Tell Us About Zai Lab Limited (ZLAB) Q2 Earnings - MSN
Zai Lab (NASDAQ:ZLAB) Now Covered by Jefferies Financial Group - Defense World
Zai Lab Limited Depositary Receipt stock volume spike explainedJuly 2025 Short Interest & Long-Term Growth Plans - Newser
Is Zai Lab Limited Depositary Receipt stock technically oversold2025 Performance Recap & Smart Swing Trading Alerts - theviewers.co.kr
Zai Lab (NASDAQ:ZLAB) Trading Down 5.9% on Insider Selling - Defense World
134,000 Annual Cases: Zai Lab's Innovative Cancer Device TTFields Fast-Tracked in China for Pancreatic Cancer - Stock Titan
Zai Lab Announces China National Medical Products Administration Grants Innovative Medical Device Designation for Tumor Treating Fields for Patients with Pancreatic Cancer - Business Wire
What recovery options are there for Zai Lab Limited Depositary Receipt2025 Short Interest & Reliable Price Action Trade Plans - Newser
Why Zai Lab Limited Depositary Receipt is moving todayExit Point & Intraday High Probability Setup Alerts - Newser
Zai Lab Establishes Oncology Scientific Advisory Board - Lelezard
Zai Lab Limited Adr (ZLAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.77%
1.53%
자본화:
|
볼륨(24시간):